Establishment of Lymphoblastoid Cell Lines from Iranian Multiple Sclerosis Patients: A Renewable Genetic Resource

Abstract Background Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disorder of the central nervous system with a complex interplay of genetic and environmental factors. The availability of high-quality, renewable sources of genomic DNA is crucial for advancing genetic and molecular investigations. This study aimed to establish a biobank of Epstein–Barr virus (EBV)-transformed lymphoblastoid cell lines (LCLs) derived from Iranian patients with MS. Methods Peripheral blood samples were collected from 72 clinically confirmed MS patients following informed consent. Peripheral blood lymphocytes were isolated using Ficoll-Paque density gradient centrifugation and immortalized through EBV transformation using supernatant derived from the B95-8 cell line. Successfully established LCLs were expanded, characterized, and cryopreserved according to standard biobanking procedures. Quality control assessments included mycoplasma screening by Hoechst staining, PCR, and culture-based methods, bacterial and fungal sterility testing, species authentication using mitochondrial COI PCR, and viral screening for HBV, HCV, HIV, and EBV. Results Stable LCLs were successfully established from 48 of the 72 collected samples, corresponding to an overall success rate of 66.7%. All established cell lines were negative for mycoplasma, bacterial, and fungal contamination. Species authentication confirmed the human origin of all cell lines, and viral screening showed no evidence of HBV, HCV, or HIV infection. The generated LCLs were systematically documented, cryopreserved, and stored in the vapor phase of liquid nitrogen with comprehensive associated metadata. Conclusion This study represents the first reported biobank of EBV-transformed LCLs established specifically from Iranian patients with MS. This renewable and well-characterized resource provides a valuable source of genomic DNA for future genetic association studies, biomarker discovery, and functional genomic investigations of MS in the Iranian population. The established cell lines are available through the Iranian Biological Resource Centre (IBRC) for qualified research purposes.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-13
DOI
https://doi.org/10.21203/rs.3.rs-11456044/v1
Primary Topic
Multiple Sclerosis Research Studies
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Establishment of Lymphoblastoid Cell Lines from Iranian Multiple Sclerosis Patients: A Renewable Genetic Resource

Mansoureh Farhangniya, Hedieh Rahmati, Mina Gholami, Sepideh Ashouri Movassagh et al.
2 links
Research Square
Multiple Sclerosis Research Studies
preprint

Establishment of Lymphoblastoid Cell Lines from Iranian Multiple Sclerosis Patients: A Renewable Genetic Resource

Mansoureh Farhangniya, Hedieh Rahmati, Mina Gholami, Sepideh Ashouri Movassagh, Abdolreza Daneshvar Amoli, Mehrnaz Izadpanah, Alireza Ahmadi, Seyed Abolhasan Shahzadeh Fazeli, Samaneh Mahmood-Aghdam
preprint en

Abstract

Abstract Background Multiple sclerosis (MS) is a chronic immune-mediated demyelinating disorder of the central nervous system with a complex interplay of genetic and environmental factors. The availability of high-quality, renewable sources of genomic DNA is crucial for advancing genetic and molecular investigations. This study aimed to establish a biobank of Epstein–Barr virus (EBV)-transformed lymphoblastoid cell lines (LCLs) derived from Iranian patients with MS. Methods Peripheral blood samples were collected from 72 clinically confirmed MS patients following informed consent. Peripheral blood lymphocytes were isolated using Ficoll-Paque density gradient centrifugation and immortalized through EBV transformation using supernatant derived from the B95-8 cell line. Successfully established LCLs were expanded, characterized, and cryopreserved according to standard biobanking procedures. Quality control assessments included mycoplasma screening by Hoechst staining, PCR, and culture-based methods, bacterial and fungal sterility testing, species authentication using mitochondrial COI PCR, and viral screening for HBV, HCV, HIV, and EBV. Results Stable LCLs were successfully established from 48 of the 72 collected samples, corresponding to an overall success rate of 66.7%. All established cell lines were negative for mycoplasma, bacterial, and fungal contamination. Species authentication confirmed the human origin of all cell lines, and viral screening showed no evidence of HBV, HCV, or HIV infection. The generated LCLs were systematically documented, cryopreserved, and stored in the vapor phase of liquid nitrogen with comprehensive associated metadata. Conclusion This study represents the first reported biobank of EBV-transformed LCLs established specifically from Iranian patients with MS. This renewable and well-characterized resource provides a valuable source of genomic DNA for future genetic association studies, biomarker discovery, and functional genomic investigations of MS in the Iranian population. The established cell lines are available through the Iranian Biological Resource Centre (IBRC) for qualified research purposes.

Research Square
Royan Institute (IR), Academic Center for Education, Culture and Research (IR), Tehran University of Medical Sciences (IR)
Academic Center for Education, Culture and Research
Good health and well-being
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon